arrow
W

Wendy Landier

University of Alabama Birmingham
H指数:49
被引数:9,493

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or marrow transplant survivors and non-cancer controls

酪氨酸激酶抑制剂治疗的慢性髓性白血病患者的健康状况受损情况与血液或骨髓移植幸存者及非癌症对照者的比较

Leukemia
IF13.4
2026-08-210
OAAI
Anthracycline-induced cardiomyopathy in childhood cancer survivors is associated with gene signatures of mitochondrial dysfunction—a COG ALTE03N1 report

儿童癌症幸存者中,由蒽环类药物诱导的心肌病与线粒体功能障碍的基因特征相关——COG ALTE03N1报告

2025-10-070
OAAI
Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group

高危神经母细胞瘤后的迟发效应(LEAHRN):一项来自儿童肿瘤组的 multicentre, cross-sectional cohort study

2025-09-250
PRE
Alternative mRNA splicing in anthracycline-induced cardiomyopathy - a COG-ALTE03N1 report

蒽环类药物诱导的心肌病中的替代性mRNA剪接——COG-ALTE03N1报告

2025-05-170
OA
A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar

基于框架的指南:将基于初级保健的儿科干预措施适应并应用于儿科肿瘤学环境——HPV PROTECT作为范例

CANCER
IF5.1
2025-04-290
OAAI
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies- a BMT Survivor Study (BMTSS)

淋巴恶性肿瘤造血干细胞移植(BMT)幸存者高风险健康行为的预测因素——造血干细胞移植幸存者研究(BMTSS)

BLOOD
IF23.1
2024-11-050
PRE
Long-Term Health Outcomes in Older (≥60 Years) Blood or Marrow Transplantation (BMT) Recipients: A Report from the Blood or Marrow Transplant Survivor Study (BMTSS)

≥60岁血液或骨髓移植(BMT)受者长期健康结局:血液或骨髓移植幸存者研究(BMTSS)报告

BLOOD
IF23.1
2024-11-050
PRE
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies- a BMT Survivor Study (BMTSS)

髓系恶性肿瘤的血或骨髓移植(BMT)幸存者中危险健康行为的影响因素——一项BMT幸存者研究(BMTSS)

BLOOD
IF23.1
2024-11-050
PRE